Kanabo Group 10/1/2024 Earnings Report

Kanabo Group EPS Results

• Actual EPS: -GBX 0.28
• Consensus EPS: N/A
• Beat/Miss: N/A
• One Year Ago EPS: N/A

Kanabo Group Revenue Results

• Actual Revenue: N/A
• Expected Revenue: N/A
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

Kanabo Group Announcement Details

• Date: 10/1/2024
• Time: Before Market Opens
• Conference Call Date: N/A
• Conference Call Time: N/A

Kanabo is creating a new standard in the medical cannabis industry by improving the well-being of millions around the world. Its focus is on the distribution of Cannabis-derived products for medical patients, and non-THC products for CBD consumers. Kanabo have conducted extensive R&D in order to develop high-quality Cannabis extract formulas, innovative medical-grade vaporisers, and various non-smoking consumption solutions – making use easy and accessible for anyone in need of treatment. Clinical and validation activities, including safety and efficiency tests, are conducted in Israel – an established leader in the Cannabis industry. The company is selling initial products in Europe already, and is ready to scale up to meet market demands and projected sales and revenues.